BMS compound 1 has such a short acting profile in vivo in rats resulting in PTH bursts [1], but the effect of the compound on BMD has yet to be studied and the hypothesis of use of calcilytics for treatment of osteoporosis thus remains to be proven. The gene discussed is PTH; the disease is osteoporosis.